Data investigation

How Much GLP-1 Prices Actually Vary

The dearest tenth of the compounded market charges about three times the cheapest tenth, not the 25x a naive calculation gives. Why the naive number is wrong, and the fifth of sellers who publish no price at all.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed
7 min read·1 citation

For the same molecule, at the same dose, from sellers who all describe themselves the same way, the dearest tenth of the market charges about three times what the cheapest tenth does. Our first calculation gave a number eight times larger, and the reasons it was wrong are more useful to a buyer than the number itself.

The spread

We computed this on August 19, 2026. Across 572 published monthly prices for compounded semaglutide, from 396 sellers, the ninetieth percentile was 3.0 times the tenth. For compounded tirzepatide, across 506 prices from 365 sellers, it was 2.7 times. The middle half of the market is tighter than people expect: the seventy-fifth percentile sat at roughly 1.3 times the median in both cases.[1]

Identical products do not cost wildly different amounts at random here. The market has a reasonably concentrated middle and a long expensive tail, so the practical question for a buyer is less “am I being overcharged” than “am I in the tail”.

A ratio is the durable way to say this. Any dollar figure we printed would be wrong within months, and every seller’s current number is already on the price tracker with the date we checked it. What does not go stale is the shape: a tight middle, a long upper tail, and a fifth of the market refusing to show you where it sits.

Why our first answer was eight times too big

The naive calculation is minimum against maximum, and it produced a spread of nearly twenty-five times. It was wrong twice over, and both errors recur wherever prices are compared.

  1. The top of the range was not the same product. The most expensive “compounded” rows were brand-name Ozempic, Wegovy, Mounjaro and Zepbound, recorded with the wrong form. Setting brand prices against compounded ones compares two different products.
  2. The bottom of the range was not a monthly price. The cheapest row was a per-vial figure at a starter dose, and its own note says it is not a recurring plan. Set against real monthly plans it makes the market look far cheaper at the floor than it is.
Minimum against maximum gave a spread of nearly twenty-five times. The top was a brand product recorded as compounded; the bottom was a per-vial starter price.

Percentiles fix this, because a single miscoded row cannot move the tenth or ninetieth percentile of five hundred. The corrected figure is therefore a ratio between percentiles.

What we found in our own data, and fixed

Chasing that top figure turned up a fault on our side. Five pricing rows recorded brand-name products as compounded, and because our scoring benchmarks each seller against the median for its drug and product type, one of them produced a published criticism that was simply wrong: a seller was described as charging 273% above the register median for compounded semaglutide, when the price in question was brand Ozempic, quoted verbatim from the seller’s own site.

The rows are reclassified, the false criticism is gone, and an automated check now fails our build if a brand product is ever priced as compounded again. It is the same discipline we ask of sellers in how to check a review score, applied to a number we generated ourselves.

The fifth of the market you cannot see

On August 19, 2026, 111 of 560 sellers published no price at all, almost exactly a fifth. Their cost appears only after an intake questionnaire, and usually after health information has been submitted.

This matters more than the spread does. A distribution you can measure is one you can shop within; the gated fifth cannot be compared against anything until you have already invested time and handed over medical details. And there is no way to know from outside whether a gated price is high or low. Presumably that is the point.

Sign-up walks show what the gate looks like in practice. T2D.com, Helix Wellness Rx and 9amHealth showed a price only after the health intake. One80Rx and Vela Rx advertise a new-patient starting figure on the homepage but leave the ongoing monthly charge unpublished, and Ravia Health publishes no GLP-1 price at all. Neither does HexisMD, a Florida telehealth clinic that publishes no price for any service; its about page says pricing is discussed during the consultation, and its weight-loss assessment ends in a request to book one. On the other side, Rx.com and Totara Health put their prices in front of you before any medical questions, each at one price for every dose. FancyMeds shows the total and takes payment before the medical intake, with compounded semaglutide at $249 per 4 weeks at every listed dose. Belle Health charges $199 a month for compounded semaglutide and $249 for tirzepatide at every dose, with free shipping and no consultation fee. Prestige Health Rx advertises a flat monthly rate and 25% off the first month, yet no public page carries a price; it appears only after an intake that asks for your name, email, phone and date of birth.

A flat price is not the same as a visible one. VivioMD says its monthly price does not rise as the dose goes up, yet its sign-up walk showed no price until the health intake was finished.

If a price appears only after an intake, treat the intake as part of the price. You are paying in personal health information for a number that a competitor published for free, and you will be inside a funnel by the time you see it. Our comparison tool filters to sellers that publish, which is the fastest way to skip that entirely.

Some sellers take the dose out of the equation. CoreAge Rx charges one monthly price for compounded semaglutide and another for compounded tirzepatide, and neither changes with the strength. BestDaysRx lists a 30-day supply of compounded semaglutide at $199 and of compounded tirzepatide with B12 at $279, at every dose it sells. Ness charges $250 a month for compounded semaglutide and $340 for tirzepatide at every dose, whether as a weekly injection or a daily tablet.

How to use this when buying

  • Compare against the median, not against the cheapest. The floor of this market is often a starter dose, a per-vial price or a promotional first month, and none of those is what you will pay ongoing. At Weight Method, compounded semaglutide is $59 for the first month for new GLP-1 patients and $205 a month after that. Drakewell Health lists compounded semaglutide at $129 for the first month and $229 a month from then on. HealthRX charges $99 for the first month of semaglutide and $165 a month after that. At Sprout Health the $99 figure is its 12-month plan, $1,188 paid up front; billed every 4 weeks, semaglutide is $149.
  • Check what the price is per, not just what it is. Per vial, per month, per quarter and per starting dose are all quoted the same way. Olivera Weight Loss prices its semaglutide starter at $299 for the first six weeks, then $346 for each 4-week supply. IonicMD says plainly that its $249 semaglutide price is charged every 4 weeks, which makes 13 charges in a year rather than 12. bmiMD’s $99 a month for compounded semaglutide is a 12-month plan charged once as $1,188; its monthly plan is $129.
  • Being above the median is not a scandal. A seller naming its pharmacy, requiring a video visit and answering the phone may be worth more than the cheapest option. Being in the top tenth without offering any of that is the thing to notice.
  • Treat a gated price as a signal in itself. A fifth of sellers do this, and the ones that publish are telling you something before you have spent a minute.

It also helps to see a price taken apart. Cost Plus Drugs prints the manufacturer cost, its markup and a pharmacy labor fee on each product page. Its one weight-management GLP-1 is generic liraglutide, the drug in Saxenda, and the prescription has to come from an outside clinician.

Frequently Asked Questions

Less than the horror stories suggest. In our August 19, 2026 computation, across 572 published monthly prices for compounded semaglutide from 396 sellers, the dearest tenth charges about three times the cheapest tenth, and for tirzepatide about 2.7 times. The middle half of the market is fairly tight; the tail is long and expensive.
Because minimum and maximum are the two values most likely to be errors. When we did that, the top of the range turned out to be brand-name products recorded with the wrong product type and the bottom was a per-vial starter price that its own note said was not a recurring plan. The naive answer was about eight times too large.
On August 19, 2026, 111 of the 560 sellers we track published no price at all, almost exactly a fifth. Their cost appears only after an intake questionnaire, usually after health information has been submitted, so it cannot be compared against anything until you are already in the funnel.
Not for the drug itself, which is the same molecule. It can reflect real differences in service, such as a named pharmacy, a video visit with a clinician or reachable support. Being above the median is not a scandal; being in the top tenth while offering none of those things is the thing to notice.
Yes. Five rows recorded brand-name products as compounded, and one of them produced a published criticism of a seller that was wrong, because it compared a brand Ozempic price against the compounded median. The rows are corrected, the criticism is removed, and an automated check now prevents it recurring.

References

  1. 1.GLP Watchdog. Provider register — 572 compounded semaglutide and 506 compounded tirzepatide monthly price rows across 560 sellers, computed August 19, 2026 GLP Watchdog register. 2026. https://glpwatchdog.org/price-tracker

Microdosing a GLP-1: What Evidence Exists

In August 2026, 62 of the 560 sellers we tracked offered a microdose product. The published literature is letters and commentary about how to answer patients who ask for it; we identified no randomized trial.

6 min read

Who Tells You How Your GLP-1 Ships?

192 sellers advertise free shipping. 29 mention keeping it cold. Degraded medication looks exactly like good medication, and the packaging is the only evidence you will ever have.

5 min read

What Makes a Telehealth GLP-1 Prescription Legitimate

The FDA publishes seven warning signs for telehealth medicine sellers. Here they are, with what proper prescribing looks like and the one disclosure that 139 of our 560 sellers failed in an August 2026 count.

7 min read

Who Actually Runs Your GLP-1 Brand

At our August 2026 count, 61 of the 560 sellers we tracked named one of just seven shared entities: one white-label platform, two prescriber networks, four compounding pharmacies. Comparing two brands can mean comparing two markups on the same vial.

7 min read

Who Responds in the Real World

Tirzepatide nearly doubled the share reaching 15% weight loss in a year. The same study found outcomes differing by race, where 64 randomized trials found none. The disagreement is the finding.

6 min read

Stretching Doses to Save Money

At list prices above a thousand dollars a month, people stretch these drugs. Two papers argue fortnightly dosing keeps most of the weight loss, on a mathematical model and a case series of two patients.

8 min read

Where to get GLP-1 online, safely: sellers our editors have checked

These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.5

Gala

Moving between compounded and brand without changing seller

7.9

Luvo Health

Moving between compounded and brand without changing seller

7.2

Oak

A choice of compounded injections, oral semaglutide and brand-name GLP-1s from one cash-pay checkout

About this analysis

GLP Watchdog publishes independently. Each seller in our dataset is checked against that seller's own website, and the dataset is updated continuously. Read our full methodology →